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Requirements for omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFA), such as 13 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), for Atlantic salmon are typically 14 
represented as an absolute level in the diet (e.g. g/kg or % of diet). Data for other species suggests that 15 
requirements for n-3 LC-PUFA are actually relative to dietary lipid (e.g. % of total fatty acids). A 2 x 16 
2 factorial design of dietary lipid level x n-3 LC-PUFA level was designed to examine this question. 17 
Atlantic salmon post-smolts of 187 ± 4 g were fed one of four diets for 116 days that either had a low 18 
or high lipid level (180 or 230 g/kg) and a low or high n-3 LC-PUFA level (7 or 14 g/kg). Fish fed the 19 
diet with high-lipid + high n-3 had greater final weight and weight gain than the high-lipid + low n-3 20 
diet, but no differences were noted between the two low-lipid diets. Significant effects of n-3 and a 21 
lipid*n-3 interaction were observed. However, no effects on feed intake, FCR and survival were found. 22 
Feeding high n-3 diets generally increased n-3 levels and retention in the whole body, especially EPA 23 
and DHA. Relative expression of lipid metabolism genes in the liver showed that fish fed high lipid + 24 
high n-3 had lower levels of expression of fatty acid synthesis genes (fads2d5, fads2d6 and elovl2). 25 
Upregulation of lipid transcription factor (srebp2 and lxr) and fatty acid beta-oxidation (hoad and aco) 26 
genes in fish fed low lipid + high n-3 further suggest that the proportion of dietary n-3 and energy level 27 
in those diets were lower than the high-lipid + high n-3 treatment. In conclusion, the significant 28 
interaction between lipid and n-3 levels on growth clearly shows that n-3 LC-PUFA requirements are 29 
relative to the lipid level in diets for Atlantic salmon. These results support the notion that requirements 30 
for this species should be defined based on a percent of total fatty acid content, implying that the 31 
absolute amount of n-3 LC-PUFA needs to increase as lipid content of the diet increases. 32 
33 
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Highlights 37 
• Highest growth for Atlantic salmon fed high lipid + high n-3 LC-PUFA diet. 38 
• Significant interaction between lipid and n-3 levels for fish growth.  39 
• Retention of n-3 LC-PUFA in the carcass was higher when fed high n-3 diets. 40 
• Up-regulation of fatty acid synthesis genes in fish fed low n-3 diets. 41 
• The n-3 LC-PUFA requirement is relative to the total lipid level in the diet. 42 
 43 
 44 
1. Introduction 45 
 46 
The omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFA), such as eicosapentaenoic acid 47 
(EPA) and docosahexaenoic acid (DHA), are conditionally-essential dietary nutrients for Atlantic 48 
salmon (Salmo salar) (Glencross, 2009) (Fig. 1). Various studies have shown that n-3 LC-PUFA are 49 
required by Atlantic salmon at a level between 10 and 15 g/kg of the diet for optimal growth (Bou et 50 
al., 2017, Glencross et al., 2014, Ruyter et al., 2000). However, this level may actually be subject to 51 
varying dietary lipid levels as there is some evidence from other species that requirements may in fact 52 
be relative not absolute (Glencross, 2009). 53 
 54 
Throughout the literature, fatty acid requirement studies have been expressed both in terms of the 55 
amount of these nutrients in the diet (g/kg) and/or the relative proportion they represented of the total 56 
fatty acids (%TFA) (Glencross, 2009). Previous studies have indicated that fatty acid requirements are 57 
better represented relative to the level of total fatty acids in other species such as rainbow trout 58 
(Oncorhynchus mykiss) (Watanabe, 1982), red sea bream (Pagrus major) (Takeuchi et al., 1992a), 59 
yellowtail (Seriola quinqueradiata) (Takeuchi et al., 1992b) and Giant tiger shrimp (Penaeus monodon) 60 
(Glencross et al., 2002). For example, Watanabe (1982) found that double the level of n-3 PUFA (18:3n-61 
3) was required when feeding 100 instead of 50 g/kg total lipid to rainbow trout. The important 62 
implication of this observation is that given that it is typical to change the lipid level in diets as species 63 
grow, then relying on a single, fixed absolute level of n-3 PUFA in the diet may in fact be pushing the 64 
diets to becoming limiting in n-3 as the lipid level increases if these nutrients are not proportionally 65 
increased. However, this approach to reporting fatty acid requirements has not be fully adopted by the 66 
aquaculture nutrition community. This is in contrast to amino acid requirements that are typically 67 
represented either or both relative to protein level and/or relative to energy level.  68 
 69 
Therefore, the objective of this study was to determine the nature of requirement responses by Atlantic 70 
salmon. To do this required a two-way factorial analysis of the effect of dietary lipid level and n-3 LC-71 
PUFA level on the respective responses by the fish, where we present an assessment of the performance, 72 
nutrient utilisation and transcriptomic responses of this species. We tested the hypothesis that n-3 LC-73 
PUFA level is relative to the total lipid level, rather than absolute level, in the diet by evaluating lipid*n-74 
3 interactions on the above response parameters. 75 
 76 
 77 
2. Materials and Methods 78 
 79 
2.1 Fish management 80 
 81 
Atlantic salmon post-smolts were acquired from a commercial hatchery (Marine Harvest, Loch Ailort, 82 
Scotland) and transferred to University of Stirling’s Marine Environmental Research Laboratory 83 
(Machrihanish, Scotland). Fish were sedated with MS222, weighed (187 ± 4; mean ± SD) and sorted 84 
into 12 circular tanks (500L) to achieve 32 fish per tank. Tanks contained 350 L of bag-filtered (100 85 
m) seawater sourced from the adjacent bay in a flow-through system. Each tank was equipped with 86 
LED lighting on a 16:8 light:dark cycle, an air stone and a probe that recorded dissolved oxygen and 87 
temperature every 10 min (Oxyguard A/S, Farum, Denmark). Fish were acclimatised to the tanks for 88 
three weeks while they were introduced to the experimental diets. Over the 17-week (116 day; 138 days 89 
including the acclimation period) experiment, temperature was 13.2 ± 0.2 oC (mean per week ± SD) 90 
and the dissolved oxygen was 92.6 ± 2.7% (8.0 ± 0.2 mg/L). The experiment was approved by the 91 
University of Stirling Animal Welfare and Ethical Review Body (reference AWERB-16/17-84) in 92 
accordance with the UK Home Office under the Animals (Scientific Procedures) Act 1986.  93 
 94 
2.2 Experimental diets and feeding 95 
 96 
The basic diet design was a simple 2 x 2 factorial, with high and low levels of lipid (HL and LL) and 97 
high and low levels of n-3 LC-PUFA (Hn3 and Ln3). Levels of n-3 LC-PUFA were planned to be 98 
slightly above and below reported critical optima (Glencross et al., 2014; Bou et al., 2017). Diets were 99 
formulated (Table 1) to be isoenergetic on a digestible basis. To achieve this the level of protein was 100 
increased in the low lipid diets (LL-Ln3 and LL-Hn3) to maintain the diets on this isoenergetic basis, 101 
while maintaining an equal amount of fishmeal (200 g/kg) in each diet. While clearly this changed the 102 
protein:energy ratio of the diets, this was considered less of an issue than not balancing the digestible 103 
energy content of the diets or using starch to manipulate digestible energy density. The n-3 LC-PUFA 104 
level in two of the diets (HL-Hn3 and LL-Hn3) was increased from 7 to 14 g/kg by additional inclusion 105 
of linseed and fish oils. Yttrium oxide was included as a digestibility marker in the diets. The 3 mm 106 
diets were produced by SPAROS I&D (Olhão, Portugal) using twin-screw extrusion, vacuum lipid 107 
coating, and were air-dried and stored at 4 oC.  108 
 109 
Each tank of fish was fed one of the four extruded diets in triplicate in a randomised block design. Diets 110 
were fed twice per day for three-hour durations using automated drum feeders (Arvo-tec Oy, 111 
Huutokoski, Finland) at a rate of about 1.0 to 1.5% of fish bodyweight per day. Feeding rations were 112 
adjusted daily based on the uneaten feed from each tank to ensure satiation. Each morning, uneaten feed 113 
was collected manually from each external tank standpipe using a sieve and was weighed. A recovery 114 
and dissolution test was performed to determine a correction factor to be applied to the wet uneaten 115 
feed waste in order to calculate the daily feed intake according to (Helland et al., 1996), which is 116 
included in the equation below.  117 
 118 
2.3 Sample collection 119 
 120 
Fish were sedated with MS222 and weighed at day 0, 21, 56 and 138 (day 116 post-acclimation period). 121 
Fish were fed until the day of sampling and faeces were stripped from all fish by gently squeezing the 122 
abdomen, pooled per tank and stored at -20 oC. At each weighing point, eight fish per tank were 123 
euthanised by an overdose of MS222 and cervical dislocation. Four fish were measured for fork length, 124 
pooled per tank (n=3/treatment) and stored at -20 oC. However, at the end of the trial one tank of fish 125 
developed symptoms of amoebic gill disease and was treated with freshwater, thus this tank was 126 
removed from growth performance analysis (i.e. HL-Hn3: n=2). Pooled faeces and whole carcass 127 
samples were homogenised and freeze dried overnight. The other four fish were dissected, liver and 128 
viscera weights were recorded to determine somatic indices and the liver was frozen in cryotubes on 129 
dry ice and stored at -70 oC for gene expression analysis. 130 
 131 
2.4 Nutritional analyses 132 
 133 
Proximate, fatty acid and mineral composition of the diets, carcasses and faeces were performed at the 134 
Institute of Aquaculture (Stirling, UK). Moisture and ash were analysed using ovens at 105 and 550 oC 135 
for approximately 24 and 12 hours, respectively according to the Association of Official Analytical 136 
Chemists (AOAC, 1995). Protein was analysed by digestion in sulphuric acid at 400 oC (FOSS A/S, 137 
Hillerød, Denmark) for one hour and then addition of sodium hydroxide by a Tecator Kjeltec system 138 
(FOSS A/S) according to the Kjeldahl Method (Persson, 2008). Gross energy was measured by ballistic 139 
bomb calorimetry using a Parr 6200 bomb calorimeter (Parr Instrument Co., Moline, IL, USA). 140 
Lipid was analysed by homogenisation in 2:1 chloroform/methanol, centrifugation, aqueous layer 141 
aspiration and nitrogen evaporation (TurboVap Classic, Biotage AB, Uppsala, Sweden) according to 142 
the Folch method (Folch et al., 1957). Fatty acids were analysed according to methods of the American 143 
Oil Chemists' Society (Christie, 2003). Fatty acid methyl esters (FAME) were made by acid-catalysed 144 
esterification of 1 mg of total lipid by overnight incubation at 50 oC with an internal standard of 17:0, 145 
sulphuric acid, methanol and toluene. A solution of 1:1 iso-hexane/diethyl ether was added and then 146 
centrifuged. The upper layer was purified through a silica cartridge, redissolved in iso-hexane and then 147 
injected onto a gas liquid chromatographer (GLC) using a Fisons GC-8160 (Thermo Scientific, Milan, 148 
Italy) equipped with a 30 m × 0.32 mm i.d. × 0.25 μm ZB-wax column (Phenomenex, Cheshire, UK), 149 
on-column injector and a flame ionisation detector. Individual FAMEs were identified by MD800 mass 150 
spectrometer (ThermoFisher Scientific, Hempstead, UK) and compared to external standards of marine 151 
oil. Data were collected and processed using Chromcard software version 2.01 (Thermoquest Italia 152 
S.p.A., Milan, Italy). 153 
 154 
2.5 Calculations of growth performance, body indices and feed efficiency 155 
 156 
Means for growth performance were generated based on per fish values from three replicate tanks, body 157 
indices were based on four representative fish per tank and nutrient utilisation was based on a pooled 158 
sample of four fish per tank. Weight gain, gain rate, feed intake (FI) and feed conversation ratio (FCR) 159 
were calculated using the following equations:  160 
Weight gain (g fish-1) = final weight – initial weight 161 
Gain rate (g fish-1 day-1) = weight gain / days 162 
FI (g fish-1) = [(Feed fed – (feed waste / correction factor)] / number of fish in each tank 163 
Protein intake (g fish-1) = FI x (diet protein % / 100) 164 
Lipid intake (g fish-1) = FI x (diet lipid % / 100) 165 
FCR = FI / weight gain 166 
 167 
Hepatosomatic index (HSI) and viscerosomatic index (VSI) were calculated according to the following 168 
equations: 169 
HSI (%) = (liver weight / final weight) x 100 170 
VSI (%) = (viscera weight / final weight) x 100 171 
 172 
Nutrient retention and apparent digestibility were calculated as: 173 
Nutrient retention (%) = [(FW x C / 100) – (SW x C / 100)] / (FI x C / 100) x 100 174 
Apparent digestibility (%) = [1 – (F / D × Di / Fi)] x 100 175 
where C is % nutrient (or MJ kg-1 for energy) in whole body carcass or diet (D), F is % nutrient (or MJ 176 
kg-1 for energy) in faeces, Di is % inert marker yttrium in diet and Fi is % inert marker yttrium in faeces. 177 
 178 
2.6 Molecular analyses using qPCR 179 
 180 
Liver samples were thawed on ice and approximately 50 mg of the apical tip was homogenised in 1 mL 181 
of Tri Reagent (Sigma-Aldrich, Dorset, UK) using a mini-bead beater (Biospec Products, Bartlesville, 182 
OK, USA) for two cycles of 45 sec with 45 sec rest period. Samples were centrifuged at 12,000 g for 183 
10 min and the upper layer was transferred to new tubes containing 1-bromo-3-chloropropane (Sigma-184 
Aldrich). The RNA solution was mixed, centrifuged at 20,000 g for 15 min, precipitated with a solution 185 
of sodium chloride (Merck KGaA, Darmstadt, Germany), sodium citrate sesquihydrate (Sigma-Aldrich) 186 
and isopropanol. Samples were centrifuged as before and the RNA pellet was washed with two washes 187 
of 70% ethanol and then air dried in a fume hood. The RNA pellet was resuspended in RNase free water 188 
and the concentration and quality was checked using a spectrophotometer (ND-1000, Nanodrop 189 
Technologies LLC, Wilmington, DE, USA). All samples had a 260/230 nm 260/280 ratios above 2.0 190 
and 1.8, respectively, or the extraction was redone. The quality was also checked by running denatured 191 
samples on a 1% agarose gel to verify RNA integrity of the two rRNA bands.  192 
 193 
From two fish per tank (n=6/treatment), 6 g was pooled and then diluted with RNase free water to 2 194 
g (200 ng/L). Samples were denatured at 75 oC for 5 min and then added to 10 L of High-capacity 195 
cDNA Reverse Transcription Kit (Applied Biosystems, Paisley, UK) containing RT buffer, dNTP, 196 
random primers, dT oligo primers, multiscribe reverse transcriptase (50 U/μL) and nuclease free water. 197 
Non-template control (NTC) and reverse transcription negative (RT-) were included for quality control. 198 
The cDNA was synthesised in a thermocycler (T Advanced, Biometra GmbH, Göttingen, Germany) 199 
with the conditions: 25 oC for 10 min, 37 oC for 120 min and 85 oC for 5 min.  200 
 201 
The qPCR efficiency was determined for every set of primers by pooling 4 L of each sample and then 202 
making a dilution series from 1/5 to 1/500. In duplicate, 2.5 L of each diluted sample (1 L for 203 
reference genes) was mixed with 5 L of Luminaris Color HiGreen qPCR mastermix (Thermo 204 
Scientific, Paisley, UK), 0.5 L of each primer (10 pmol) and nuclease free water in 10 L reactions, 205 
along with a NTC. The qPCR was performed in a thermocycler (T Professional, Biometra GmbH) under 206 
conditions: 50 oC for 2 min, 95 oC for 10 min and 35 cycles of 95 oC for 15 sec, 60 oC for 30 sec and 72 207 
oC for 30 sec. All primer efficiencies (E) were between 90-105% and the Ct of each target gene was 208 
calibrated against the control treatment of high lipid + high n-3 (delta Ct = calibrator Ct – sample Ct). 209 
The relative gene expression was calculated based on relative quantity (RQ = E^delta Ct) between the 210 
target and the geometric mean of two reference genes (RQ target / RQ reference) (Pfaffl et al., 2000). 211 
Four reference genes (Table 2) were compared using Genorm (Vandesompele et al., 2002) and hprt and 212 
rps5 were selected to be the most stable genes.  213 
 214 
2.7 Statistical analysis 215 
 216 
Normal distribution and homogeneity of each dataset were determined using Shapiro-Wilk and Levene 217 
tests in Rstudio software version 1.0.143 (R-Core-Team, 2015). If needed, data were normalized by 218 
log-transformation. All data are presented as means ± SE unless otherwise specified. Akaike's An 219 
Information Criterion (AIC) was used to determine the statistical model that best fitted the data. 220 
Significant differences between treatments were determined using linear models (lm) for phenomic and 221 
nutrient data and linear mixed effects (lme) models for gene expression data based on the nlme R 222 
package (Pinheiro et al., 2014). Both lm and lme models included fixed effects of lipid and n-3 LC-223 
PUFA as well as an interaction, except lme included random effect of tank since there was two pooled 224 
samples per tank for the transcriptomic data. P-values of each factor and interaction were generated 225 
using ANOVA tables and below 0.05 were considered significant and below 0.10 was considered to be 226 
a tendency. P-values among treatments were determined using Fisher’s least significant difference test 227 
(LSD.test) for multiple comparisons based on the agricolae R package (de Mendiburu, 2020).  228 
 229 
 230 
3. Results 231 
 232 
3.1 Growth performance and feed efficiency 233 
 234 
The levels of dietary lipid/protein (Lipid) and n-3 LC-PUFA in this experiment influenced several 235 
parameters of fish growth and feed efficiency (Table 4 and Fig. 2). Effects of n-3 and a Lipid*n-3 236 
interaction were found for final weight, weight gain and gain rate. Growth of fish fed the HL-Hn3 diet 237 
was significantly higher than that of fish fed the HL-Ln3 diet, while growth of fish fed the LL-Ln3 or 238 
LL-Hn3 diets was similar. Protein and lipid intake, HSI and VSI were significantly affected by diet 239 
lipid level. Protein intake was higher in the LL diets and lipid intake and VSI were higher in the HL 240 
diets. 241 
 242 
3.2 Whole body composition, nutrient retention and digestibility 243 
 244 
Proximate composition of whole-body carcasses were only influenced by dietary lipid level, with no 245 
effects of n-3 (Table 5). Ash, lipid and energy were elevated in the HL treatments, whereas protein was 246 
reduced. Lipid and n-3 significantly affected almost every fatty acid level in the whole body represented 247 
as % of total fatty acid, but a Lipid*n-3 interaction was found for a few monoenes and n-3 PUFA (Table 248 
5). Both lipid and n-3 levels affected total saturates, monoenes, n-3 PUFA, PUFA and LC-PUFA where 249 
low lipid and high n-3 typically increased levels found in the whole body. Total n-6 PUFA were only 250 
influenced by lipid levels, resulting in high n-6 levels when fed low lipid diets. High n-3 diets resulted 251 
in higher levels of EPA and DHA in the whole body. 252 
 253 
Only lipid level influenced retention of protein while only n-3 level influenced the retention of fatty 254 
acids in the whole body carcass (Table 6). Retention of total saturates and monoenes were not influenced 255 
at all, whereas total n-6, n-3, PUFA and LC-PUFA were affected by the level of n-3 that typically 256 
resulted in higher retention for the high n-3 diets. EPA retention was higher in fish fed high n-3 diets, 257 
while DHA retention was unaffected. 258 
 259 
Apparent digestibility of protein, lipid and energy were influenced by lipid and/or n-3 dietary levels, 260 
while only a few fatty acids were affected (Table 7). HL diets generally increased the digestibility of 261 
protein and energy, while Hn3 diets decreased the digestibility of lipid. A lipid*n-3 interaction existed 262 
for protein digestibility and it was significantly higher for the HL-Hn3 diet. The digestibility of total 263 
saturates were influenced by n-3 level, total monoenes were influenced by dietary lipid and no effects 264 
were found on total n-6, n-3, PUFA and LC-PUFA, including EPA and DHA. 265 
 266 
3.3 Differential gene expression in the liver 267 
 268 
The expression of 9 out of 13 genes related to lipid metabolism in the liver were influenced by lipid, n-269 
3 and/or lipid*n-3 interaction (Fig. 2-4). For fatty acid synthesis, low lipid and low n-3 diets increased 270 
expression of fads2d5 and fads2d6 where the HL-Hn3 diet had significantly lower expression (Fig. 3). 271 
Also, LL diets tended to increase elovl2 expression. For transcription factors, a Lipid*n-3 interaction 272 
was found for srebp1, srebp2 and lxr genes that had significantly increased expression for the LL-Hn3 273 
diet (Fig. 4). For beta-oxidation of fatty acids, HL diets increased expression of cpt1b and a lipid*n-3 274 
interaction existed for hoad and aco that showed increased expression in fish fed the LL-Hn3 diet (Fig. 275 
5).  276 
  277 
4. Discussion 278 
 279 
4.1 Dietary lipid and n-3 LC-PUFA on feed intake and growth performance 280 
 281 
An interaction between lipid and n-3 LC-PUFA levels on growth performance (Table 4 and Fig. 2) 282 
provide further evidence that the level of n-3 LC-PUFA (i.e. EPA and DHA) required by Atlantic 283 
salmon is proportional/relative to the total lipid level rather than the absolute level in the diet. These 284 
results are in agreement with previous research that demonstrated that n-3 fatty acids are better 285 
represented by the proportionality of total fatty acids (Glencross et al., 2002, Watanabe, 1982). In this 286 
study, both Hn3 diets had the same absolute level of n-3 LC-PUFA (i.e. 14 g/kg of diet), as did the two 287 
Ln3 diets (i.e. 7 g/kg of diet), although each of the diets differed in their relative levels of n-3 LC-PUFA 288 
(i.e. 3, 5, 7 and 9% of total fatty acids; TFA) (Table 2). Increased growth of fish fed the HL-Hn3 relative 289 
to the HL-Ln3 treatment is inline with previous studies that stipulate the required level of n-3 LC-PUFA 290 
in the diet is between 10 to 15 g/kg (Bou et al., 2017, Glencross et al., 2014). In comparison, the equal 291 
growth of fish fed the two LL treatments suggests that the n-3 LC-PUFA requirement is proportional 292 
and not entirely based on an absolute level between 10 to 15 g/kg. Given that the diets were formulated 293 
to be equal in terms of digestible energy in order to compare the interaction between dietary lipid and 294 
n-3 LC-PUFA levels, the lack of a difference between treatments in feed intake is perhaps not surprising 295 
(Tables 1 and 4). Because the fish were fed to satiety, the similar feed intake across treatments indicates 296 
that the fish are clearly eating to an energy demand and not an essential nutrient demand, as there was 297 
no observation that the fish were adjusting appetite to compensate for any key nutrient differences 298 
among the diets (see Fig. 1).  299 
 300 
The higher dietary lipid level, even with a slightly lower proportion of dietary EPA and DHA (i.e. HL-301 
Hn3 diet) resulted in a numerically better fish growth performance than the LL-Hn3 diet, suggesting 302 
that the energetic role of the dietary lipid also plays an important role beyond the n-3 LC-PUFA story. 303 
This may reflect subtle differences in the net energy value of the diets, and that Atlantic salmon 304 
metabolise energy from lipid more effectively than protein and therefore, despite that the digestible 305 
energy levels of the diets being close, the net energy values of the diets were likely more divergent 306 
(Phan et al., 2019). Previous studies found that feeding higher levels of total lipid and n-3 LC-PUFA 307 
increased growth of rainbow trout and shrimp, although over-supplementation of both resulted in 308 
reduced growth (Glencross et al., 2002, Watanabe, 1982). However, the proportion of n-3 LC-PUFA in 309 
the LL-Hn3 diet in the present study was similar to previous studies (i.e. 5 to 10% TFA) that resulted 310 
in optimal growth of Atlantic salmon (Glencross et al., 2014, Bou et al., 2017), which further supports 311 
the notion of a net energy imbalance. This would also explain similar growth of fish fed both LL diets 312 
with n-3 LC-PUFA levels of 5 and 9% TFA, respectively (see Fig. 6). However, seasonal effects, such 313 
as water temperature, have been found to effect protein, lipid and energy retentions in post-smolt salmon 314 
fed diets based on high and low protein-lipid ratio (Dessen et al., 2017). Other environmental 315 
conditions, such as hypoxia, may also play a role in dietary requirements (Glencross, 2009). In addition, 316 
life stage is known factor as Atlantic salmon fry require a lower level of dietary lipid (e.g. 80 g/kg) and 317 
hence a higher proportion of n-3 LC-PUFA (e.g. >10% TFA) (Ruyter et al., 2000). 318 
 319 
4.2 Dietary lipid and n-3 LC-PUFA on nutrient retention and digestibility 320 
 321 
Altering the levels of protein, lipid and fatty acids in the diet had clear effects on the composition of the 322 
whole-body carcass that reflected the diet (Table 5). These results agree with previous studies that have 323 
found that feeding high levels of n-3 LC-PUFA results in higher levels in the body or muscle of salmon 324 
(Betancor et al., 2014, Betancor et al., 2017, Hixson et al., 2017, Glencross et al., 2014). The retention 325 
of n-3 PUFA, especially DHA, in the body indicates that deposition of these essential fatty acids are 326 
preferred over others (Table 6). In contrast, previous studies have found that higher levels of n-3 PUFA, 327 
such as DHA and EPA, did not result in higher retention in the whole body or flesh of salmon and can 328 
even decrease with increased dietary inclusion (Glencross et al., 2014, Bell et al., 2004, Bell et al., 329 
2001). 330 
 331 
Increased (numerical, but not significant) growth of fish fed the HL-Hn3 diet (Table 4) may be 332 
explained by a higher net energy value from that diet compared to the LL-Hn3 diet (high protein), due 333 
to the lower net energy values from protein. Although digestible energy values were accounted for in 334 
the formulation, that protein has a higher heat increment of feeding than lipid may result in higher 335 
metabolic cost and subsequently result in lower net energy values from those diets (Kaushik and 336 
Médale, 1994). Higher energetic costs may also explain why fish fed the LL-Hn3 diet had numerically 337 
lower growth. In addition, higher net energy values for fish fed HL diets may have resulted in slight 338 
improvements in nutrient utilisation since fish fed HL diets had higher retention of protein as well as 339 
higher digestibilities of protein and energy (Tables 6 and 7). However, higher protein utilisation may 340 
be due to lower protein content in the HL diets and/or the quality of raw ingredients. Similar lipid, n-3 341 
and lipid*n-3 interaction effects were found for protein digestibility of Atlantic salmon (Bendiksen et 342 
al., 2003), although different lipid levels and oil type were fed to parr. In this study, the interaction 343 
between lipid and n-3 LC-PUFA on growth performance further supports the inclusion of n-3 LC-PUFA 344 
relative to lipid level, especially since lipid level can affect net energy values and feed utilisation in 345 
Atlantic salmon. 346 
 347 
The significant effect of n-3 level on lipid digestibility agrees with previous studies on salmonids 348 
(Caballero et al., 2002, Karalazos et al., 2011), although no effects on specific n-3 PUFA or LC-PUFA 349 
digestibilities were found (Table 7). Previous studies have found reduced digestibility of n-3 PUFA, 350 
especially EPA, when rainbow trout were fed diets based on a mixture of vegetable oils (Caballero et 351 
al., 2002). In Atlantic salmon, replacing fish oil with rapeseed oil reduced EPA (tendency) and DHA 352 
(significant) (Karalazos et al., 2011). In this study, digestibility of EPA and DHA was slightly decreased 353 
(not significant) for fish fed low n-3 diets, but this lack of effect may be due to the subtle difference 354 
between the high and low n-3 diets as opposed to replacing large proportions of fish oil with vegetable 355 
oil.  356 
 357 
4.3 Dietary lipid and n-3 LC-PUFA influences hepatic gene expression 358 
 359 
The results indicate that both lipid and n-3 LC-PUFA levels in the diet influence the transcriptomic 360 
pathway for fatty acid synthesis, regulation and beta-oxidation in the liver of Atlantic salmon (Fig. 3-361 
5). Reduced expression of fatty acid desaturases and elongases, such as fads2d5 and elolv2, in fish fed 362 
high n-3 diets (Fig. 3) agrees with previous studies that have fed fish oil with higher n-3 LC-PUFA to 363 
salmon in comparison to vegetable oils (Zheng et al., 2005, Leaver et al., 2008b, Betancor et al., 2014, 364 
Hixson et al., 2017). Upregulation of desaturases and elongases commonly results in an increased 365 
production of intermediate products (i.e. 20:4n-3 and 22:5n-3) during EPA and DHA synthesis from 366 
18:3n-3, which may explain the retention greater than 100% for DHA in the present study. The reduced 367 
level of expression of fatty acid elongation (elovl2 and elovl5a) and desaturation (fads2d5 and fads2d6) 368 
genes supports that the higher level of dietary n-3 LC-PUFA was sufficient at meeting the requirement 369 
for Atlantic salmon. 370 
 371 
Upregulation of transcription factors, such as srebp and lxr, in fish fed the LL-Hn3 diet (Fig. 4) indicates 372 
the activation of the cholesterol and PUFA biosynthesis pathways (Leaver et al., 2008a), which may be 373 
due to low levels of lipid in the diet. Previous studies have found increased expression of srebp1 and/or 374 
srebp2 in the liver or muscle of Atlantic salmon fed diets with low n-3 PUFA (Leaver et al., 2008b, 375 
Hixson et al., 2017, Betancor et al., 2014). In contrast, expression of srebp1 was not increased in fish 376 
fed the low n-3 diets in this study although differences in n-3 levels between low and high diets were 377 
considerably less than previous studies that replaced large portions of fish oil with vegetable oil (Table 378 
1). In mammals, srebp1 is involved in fatty acid metabolism and de novo lipogenesis, whereas srebp2 379 
is involved with cholesterol metabolism (Horton et al., 2003). Upregulation of srebp2 and cholesterol 380 
synthesis has been found in lean rather than fat family groups of Atlantic salmon (Morais et al., 2011), 381 
which agrees with fish fed the LL-Hn3 diet in this study. In addition, lxr is activated by a variety of 382 
sterols, including intermediates in the synthesis of cholesterol (Horton et al., 2003). Studies on the 383 
transcriptome of Atlantic salmon in response to varying DHA levels have found that sterol synthesis 384 
pathways are one of the more notable pathways affected (Glencross et al., 2015). Another recent study 385 
on Atlantic salmon found that high levels of n-6 and n-3 PUFA in the diet were positively correlated to 386 
cholesterol synthesis and suggested PUFA and cholesterol were required together to maintain cell 387 
membrane fluidity (Hixson et al., 2017). Therefore, significant upregulation of srebp2 and lxr in the 388 
liver of fish fed the LL-Hn3 diet in this study suggests that cholesterol synthesis pathways were 389 
activated, potentially to compensate for lower cholesterol supply due to low lipid in the diet while being 390 
stimulated by high dietary n-3 LC-PUFA.  391 
 392 
The upregulation of the genes for cpt1, hoad and aco in the liver of fish fed the LL-Hn3 diet (Fig. 5) 393 
indicates that the fatty acid beta-oxidation pathway was activated to generate more energy or DHA 394 
(Leaver et al., 2008a). Since this diet has high n-3 and low lipid levels, it is more likely that the 395 
upregulation of beta-oxidation genes is a catabolic response to provide fish with more energy. This is 396 
also supported by the fact that the DHA level in the whole body carcass was similar between fish fed 397 
either of the high n-3 diets (Table 5), while expression of beta-oxidation genes was only increased in 398 
the LL-Hn3 diet. Previous studies have found that feeding fish oil high in n-3 PUFA, especially EPA 399 
and DHA, resulted in upregulation of beta-oxidation genes, such as cpt1 and aco, in the liver of Atlantic 400 
salmon compared with feeding vegetable oil (Stubhaug et al., 2007, Jordal et al., 2005). In the beta-401 
oxidation pathway, cpt1 activates and transports LC-PUFA into the mitochondrial matrix for 402 
catabolism, hoad catalyses the third step of beta-oxidation in the mitochondria and aco catalyses the 403 
rate-limiting step in the peroxisome (Jordal et al., 2005, Leaver et al., 2008b). Therefore, upregulation 404 
of beta-oxidation genes in fish fed LL-Hn3 demonstrates an increased demand for energy rather than n-405 
3 LC-PUFA. 406 
 407 
4.4 Conclusion 408 
 409 
The significant interaction between dietary levels of lipid and n-3 LC-PUFA on growth in the present 410 
study provides a clear indication that the requirement for n-3 LC-PUFA by Atlantic salmon is relative 411 
to the total lipid level, rather than based on the absolute level in the diet. As such, we suggest that n-3 412 
LC-PUFA requirements should in fact be expressed based on their proportion of the total fatty acids 413 
(i.e. %TFA). Our results agreed with previous studies that found an optimal dietary level of n-3 LC-414 
PUFA was between 10 to 15 g/kg (Ruyter et al., 2000, Bou et al., 2017, Glencross et al., 2014), or more 415 
precisely a relative proportion between 5 and 8% TFA (see Fig. 6). However, this requirement is based 416 
primarily on key phenomic responses under ideal conditions and further work is needed to examine 417 
growth and immunological responses of Atlantic salmon under non-ideal conditions, e.g. hypoxia or 418 
higher thermal regimes. 419 
 420 
Additionally, this study also showed that a higher level of lipid in the high n-3 diet, despite being equal 421 
in digestible energy, allowed better growth performance. Increased growth of fish fed HL-Hn3 diet may 422 
be explained by a higher net energy value from that diet compared to the lower lipid (high protein) diets, 423 
due to the lower net energy values from protein, despite that digestible energy values were accounted 424 
for in the formulation. Levels and retentions of n-3 PUFA, especially EPA and DHA, were increased 425 
in the whole-body carcass of fish fed the HL-Hn3 diet and indicated both energy and nutrient 426 
dependencies were met. These findings were also supported by various transcriptomic responses in the 427 
liver, which showed reduced expression of fatty acid desaturases and elongase in fish fed the high n-3 428 
diets. In addition, elevated transcription factors and beta-oxidation in fish fed the LL-Hn3 diet further 429 
shows that the n-3 and energy levels in the diet may be insufficient, consistent with an interaction story. 430 
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  538 
Tables 539 
 540 
Table 1. Diet formulation and proximate composition. 541 
  HL-Ln3 LL-Ln3 HL-Hn3 LL-Hn3 
Formulation (g kg-1)         
Fishmeal1  200 200 200 200 
Soy protein concentrate2 180 64 180 64 
Soy protein isolate 115 300 115 300 
Wheat meal 145 100 145 100 
Wheat gluten 92 113 92 113 
Fish oil3 11 11 38 38 
Linseed oil 2 2 8 8 
Olive oil 194 144 161 111 
L-Histidine 8 8 8 8 
DL-Methionine 2 3 2 3 
L-Lysine 2 5 2 5 
L-Taurine 4 5 4 5 
Dicalcium phosphate 20 20 20 20 
Vitamin & Mineral Premix4 10 10 10 10 
Yttrium oxide 2 2 2 2 
Antioxidant (Paramega™)5 1.5 1.5 1.5 1.5 
Soy Lecithin 10 10 10 10 
Astaxanthin (Carophyll Pink™)6 0.5 0.5 0.5 0.5 
Choline chloride 1 1 1 1 
Proximate composition as measured (g kg-1 dry matter)  
Dry matter 938 947 941 950 
Protein 475 590 490 591 
Digestible Protein 442 542 458 548 
Lipid 241 192 222 187 
Ash 85 83 85 83 
Carbohydrate7 199 136 203 139 
Gross Energy (MJ kg-1) 24.2 23.6 23.7 23.1 
Digestible Energy (MJ kg-1) 21.5 20.7 21.0 20.3 
Calcium (Ca) 18 17 18 18 
Phosphorus (P) 13 13 13 14 
HL; high lipid, Hn3; high n-3 LC-PUFA, LL; low lipid, Ln3; low n-3 LC-PUFA. 542 
1Norvik LT70 (704 g kg-1 protein and 63 g kg-1 lipid; Sopropêche, France) 543 
2Soycomil (624 g kg-1 protein and 4 g kg-1 lipid; ADM Animal Nutrition, Decatur, IL, USA) 544 
3Savinor (10.5% EPA and 15.7% DHA; Savinor UTS, Covelas TRF, Portugal) 545 
4Neovia (formerly Invivo); Vannes, France.  546 
5Paramega (blend of natural mixed-tocopherols); Kemin, Herentals, Belgium.  547 
6CarophyllPink (10% astaxanthin); DSM, Village-Neuf, France.  548 
7Carbohydrate, calculated by difference (i.e. CHO = 1000 - protein - lipid - ash) 549 
  550 
Table 2. Diet fatty acid composition (% of total fatty acids) . 551 
 552 
HL; high lipid, Hn3; high n-3 LC-PUFA, LL; low lipid, Ln3; low n-3 LC-PUFA. 553 
1Fatty acids <0.2% not reported. 554 
  555 
 Fatty acids1 HL-Ln3 LL-Ln3 HL-Hn3 LL-Hn3 
14:0 0.5 0.6 1.4 1.7 
16:0 12.4 13.1 13.0 14.4 
18:0 2.9 2.9 3.3 3.2 
20:0 0.4 0.3 0.3 0.3 
Total saturates 16.5 17.2 18.3 20.0 
16:1n-9 0.2 0.2 0.2 0.2 
16:1n-7 1.5 1.6 2.2 2.7 
18:1n-9 61.8 58.7 56.2 48.4 
18:1n-7 3.8 3.6 3.0 2.5 
20:1n-9 0.6 0.7 0.7 0.9 
22:1n-11 0.4 0.5 0.5 0.7 
24:1n-9 0.2 0.2 0.2 0.2 
Total monoenes 68.9 66.0 63.6 56.3 
18:2n-6 10.5 12.0 9.2 11.5 
20:4n-6 0.1 0.1 0.2 0.2 
Total n-6 PUFA 10.6 12.2 9.6 11.9 
18:3n-3 1.5 1.7 2.8 3.5 
18:4n-3 0.2 0.2 0.5 0.6 
20:5n-3 1.0 1.2 2.7 3.5 
22:5n-3 0.1 0.1 0.3 0.4 
22:6n-3 0.9 1.1 1.8 2.5 
Total n-3 PUFA 3.7 4.3 8.3 10.8 
Total PUFA 14.6 16.8 18.2 23.7 
Total LC-PUFA 2.1 2.6 5.3 7.0 
n-6/n-3 2.9 2.8 1.2 1.1 
Table 3. Information on the qPCR primer pairs for reference and target genes. 
Function Gene Full name Primers Length Accession Number 
Reference cfl2 Cofilin-2 AGCCTATGACCAACCCACTG 224 TC63899b 
      TGTTCACAGCTCGTTTACCG     
  hprt Hypoxanthine phosphoribosyl-transferase 1  GATGATGAGCAGGGATATGAC 165 XM_014212855.1a 
      GCAGAGAGCCACGATATGG     
  rpl2 Ribosomal protein L2 TAACGCCTGCCTCTTCACGTTGA 112 XM_014137227.1a 
      ATGAGGGACCTTGTAGCCAGCAA   
  rps5 Ribosomal protein S5  AACTCCATGATGATGCACGG 284 XM_014142016.1a 
      GGTCTTGATGTTCCTGAAAGCA     
Fatty acid  fads2d5 Delta-5 fatty acyl desaturase GCCACTGGTTTGTATGGGTG 148 NM_001123542.2a 
 synthesis     TTGAGGTGTCCACTGAACCA     
  fads2d6 Delta-6 fatty acyl desaturase TCCTCTGGTGCGTACTTTGT 163 NM_001123575.2a 
      AAATCCCGTCCAGAGTCAGG     
  elovl2 Fatty acyl elongase 2 GGTGCTGTGGTGGTACTACT 190 NM_001136553.1a 
      ACTGTTAAGAGTCGGCCCAA     
  elovl5a Fatty acyl elongase 5 isoform a TGTTGCTTCATTGAATGGCCA 150 GU238431.1a 
      TCCCATCTCTCCTAGCGACA     
  elovl5b Fatty acyl elongase 5 isoform b CTGTGCAGTCATTTGGCCAT 192 NM_001136552.1a 
      GGTGTCACCCCATTTGCATG     
  fas Fatty acid synthase ACCGCCAAGCTCAGTGTGC 212 CK876943a 
      CAGGCCCCAAAGGAGTAGC     
Transcription lxr Liver X receptor GCCGCCGCTATCTGAAATCTG 210 FJ470290a 
 factor     CAATCCGGCAACCAATCTGTAGG   
  srebp1 Sterol regulatory element binding protein 1 GCCATGCGCAGGTTGTTTCTTCA 151 TC148424a 
      TCTGGCCAGGACGCATCTCACACT   
  srebp2 Sterol regulatory element binding protein 2 GACAGGCACAACACAAGGTG 147 DY733476a 
      CAGCAGGGGTAAGGGTAGGT     
Fatty acid  aco Acyl-CoA oxidase  AAAGCCTTCACCACATGGAC 230 TC49531a 
 β-oxidation     TAGGACACGATGCCACTCAG     
  cpt1a Carnitine palmitoyl transferase 1a TCGATTTTCAAGGGTCTTCG 166 AF327058a 
      CACAACGATCAGCAAACTGG     
  cpt1b Carnitine palmitoyl transferase 1b CCCTAAGCAAAAAGGGTCTTCA 149 AJ606076a 
      CATGATGTCACTCCCGACAG     
  hoad 3-hydroxyacylCoA-dehydrogenase GGACAAAGTGGCACCAGCAC 145 tcad0001a.i.15 3.1.omc 
      GGGACGGGGTTGAAGAAGTG     
a GenBank database (http://www.ncbi.nlm.nih.gov). b Atlantic salmon Gene Index (http://compbio.dfci.harvard.edu/tgi). c Sigenae database (http://www.sigenae.org)  
 
 
Table 4. Growth performance, feed efficiency and body indices of Atlantic salmon post-smolts. 
  Diets  Main Effect Means  P-values1 
  HL-Ln3 LL-Ln3 HL-Hn3 LL-Hn3 Pooled SE LL HL Ln3 Hn3 Pooled SE Lipid n3 Lipid x n3 
Initial weight (g fish-1)* 187.7 186.4 191.7 185.0 2.3 185.7 189.3 187.0 187.7 1.7 0.160 0.676 0.293 
Final weight (g fish-1) 505.3a 525.3ab 552.0b 524.8ab 7.1 525.1 524.0 515.3 535.7 8.8 0.923 0.069 0.043 
Weight gain (g fish-1) 317.6a 338.9ab 360.3b 339.8ab 8.2 339.3 334.7 328.3 348.0 8.7 0.795 0.096 0.079 
Gain rate (g fish-1 day-1) 2.74a 2.92ab 3.11b 2.93ab 0.07 2.93 2.89 2.83 3.00 0.07 0.809 0.099 0.086 
Feed intake (g fish-1) 280.6 297.0 317.6 283.5 15.2 290.2 295.4 288.8 297.1 13.0 0.757 0.650 0.226 
Protein intake (g fish-1) 125.1 166.0 146.5 159.2 7.5 162.6 133.6 145.5 154.1 7.5 0.017 0.549 0.168 
Lipid intake (g fish-1) 60.6 54.3 64.0 50.0 3.0 52.2 63.0 57.5 56.7 3.2 0.026 0.937 0.221 
FCR (feed:gain) 0.88 0.88 0.88 0.83 0.03 0.86 0.88 0.88 0.85 0.03 0.639 0.618 0.655 
Survival (%) 98.6 95.8 97.9 98.6 1.8 97.3 98.4 97.3 98.4 1.2 0.526 0.526 0.386 
HSI2 1.13 1.06 1.13 1.02 0.04 1.04 1.13 1.10 1.06 0.03 0.079 0.649 0.612 
VSI2 8.45bc 6.83a 8.67c 6.98ab 0.36 6.90 8.54 7.64 7.65 0.38 0.010 0.715 0.944 
*Initial weight is the weight at the end of the three-week acclimation period. FCR; feed conversion ratio, HSI; hepatosomatic index; HL; high lipid, Hn3; high n-3 LC-PUFA, LL; low lipid, 
Ln3; low n-3 LC-PUFA;VSI; viscerosomatic index. 
1P-values from linear model with lipids and n-3 LC-PUFA (n3) as fixed effects and a lipid x n3 interaction. P-values in bold are <0.10. 
2n=12, 4 fish were sampled in each triplicate tank.  
Table 5. Whole body proximate (g kg-1 wet matter basis) and fatty acid (% of total fatty acids) composition of Atlantic salmon (n=3, pooled per tank) 
  Diets Pooled Main Effect Means Pooled P-values 
  Initial HL-Ln3 LL-Ln3 HL-Hn3 LL-Hn3 SE LL HL Ln3 Hn3 SE Lipid   n3   Lipid x n3 
Dry matter 304 315 310 315 313 3.7 312 315 313 314 2.5 0.408 0.707 0.779 
Ash 18 16ab 18b 15a 18b 0.6 18 16 17 17 0.5 0.021 0.430 0.537 
Protein 167 185a 195b 182a 195b 2.2 195 184 190 189 2.3 0.002 0.634 0.481 
Lipid 101 92ab 83a 102b 89ab 4.1 86 97 88 95 3.5 0.040 0.124 0.655 
Energy (MJ kg-1) 8.1 8.6 8.3 8.7 8.4 1.5 8.3 8.6 8.4 8.6 0.1 0.094 0.472 0.700 
Fatty acids2                   
14:0 3.7 1.4a 1.6b 1.9c 2.1d 0.02 1.8 1.6 1.5 2.0 0.1 <0.001 <0.001 0.376 
16:0 13.5 12.4a 13.1b 12.8ab 13.8c 0.15 13.4 12.6 12.8 13.3 0.2 0.001 0.008 0.278 
18:0 3.1 3.4a 3.6ab 3.4a 3.7b 0.05 3.6 3.4 3.5 3.6 0.0 0.007 0.274 0.532 
20:0 0.2 0.3a 0.2bc 0.2ab 0.2c 0.01 0.2 0.2 0.2 0.2 0.0 0.002 0.077 0.696 
Total saturates 21.2 17.7a 18.7b 18.6b 20.1c 0.18 19.4 18.2 18.2 19.3 0.3 <0.001 <0.001 0.220 
16:1n-9 0.3 0.5b 0.5b 0.4a 0.4a 0.02 0.5 0.5 0.5 0.4 0.0 0.662 <0.001 0.773 
16:1n-7 4.4 2.1a 2.3b 2.6c 2.9d 0.03 2.6 2.4 2.2 2.8 0.1 <0.001 <0.001 0.078 
18:1n-9 29.9 53.1c 49.4b 49.1b 43.6a 0.18 46.5 51.1 51.2 46.4 1.1 <0.001 <0.001 0.002 
18:1n-7 3.8 3.0 3.0 2.9 2.8 0.10 2.9 2.9 3.0 2.9 0.1 0.844 0.244 0.936 
20:1n-9 4.2 3.5b 3.4b 3.2a 3.1a 0.05 3.2 3.3 3.4 3.2 0.1 0.103 0.001 0.855 
22:1n-11 3.7 0.9a 1.0ab 1.0a 1.1b 0.04 1.1 0.9 1.0 1.0 0.0 0.022 0.173 0.449 
22:1n-9 0.6 0.4a 0.4b 0.4a 0.4ab 0.01 0.4 0.4 0.4 0.4 0.0 0.014 0.253 0.803 
24:1n-9 1.3 0.3a 0.4ab 0.4bc 0.4c 0.01 0.4 0.4 0.4 0.4 0.0 0.026 0.005 0.641 
Total monoenes 48.9 64.5c 61.0b 60.6b 55.6a 0.24 58.3 62.5 62.8 58.1 1.0 <0.001 <0.001 0.022 
18:2n-6 9.8 7.9a 9.4b 8.2a 9.8c 0.11 9.6 8.1 8.7 9.0 0.2 <0.001 0.022 0.575 
18:3n-6 0.2 0.3b 0.4c 0.2a 0.2a 0.01 0.3 0.2 0.3 0.2 0.0 0.008 <0.001 0.493 
20:2n-6 0.7 0.8a 1.0c 0.8b 1.1d 0.02 1.0 0.8 0.9 1.0 0.0 <0.001 0.001 0.482 
20:3n-6 0.2 0.7c 0.8d 0.4a 0.5b 0.02 0.7 0.6 0.8 0.5 0.0 0.001 <0.001 0.629 
20:4n-6 0.4 0.4b 0.5c 0.3a 0.3ab 0.01 0.4 0.3 0.4 0.3 0.0 0.006 0.001 0.406 
Total n-6 PUFA 11.5 10.2a 12.2b 10.0a 12.1b 0.11 12.1 10.1 11.2 11.0 0.3 <0.001 0.370 0.708 
18:3n-3 3.0 1.2a 1.4b 2.0c 2.4d 0.03 1.9 1.6 1.3 2.2 0.1 <0.001 <0.001 0.004 
18:4n-3 1.1 0.4a 0.4b 0.5c 0.5d 0.01 0.5 0.4 0.4 0.5 0.0 <0.001 <0.001 0.123 
20:4n-3 0.8 0.3a 0.3b 0.4c 0.5d 0.01 0.4 0.4 0.3 0.5 0.0 <0.001 <0.001 0.008 
20:5n-3 3.7 1.3a 1.3a 1.9b 1.9b 0.03 1.6 1.6 1.3 1.9 0.1 0.441 <0.001 0.406 
22:5n-3 1.3 0.5a 0.6b 0.8c 0.9d 0.01 0.7 0.6 0.5 0.8 0.0 0.001 <0.001 0.157 
22:6n-3 6.9 3.4a 3.7a 4.5b 5.0b 0.17 4.3 4.0 3.6 4.7 0.2 0.078 <0.001 0.416 
Total n-3 PUFA 17.4 7.3a 7.8a 10.4c 11.7d 0.20 9.7 8.8 7.5 11.0 0.5 0.003 <0.001 0.098 
Total PUFA 29.9 17.8a 20.3b 20.8b 24.4c 0.29 22.3 19.3 19.0 22.6 0.8 <0.001 <0.001 0.151 
Total LC-PUFA 14.8 7.6a 8.4b 9.5c 10.8d 0.20 9.6 8.6 8.0 10.2 0.4 0.001 <0.001 0.258 
 
HL; high lipid, Hn3; high n-3 LC-PUFA, LL; low lipid, Ln3; low n-3 LC-PUFA, SE; pooled standard error of the mean.  
1P-values from linear model with lipids and n-3 LC-PUFA (n3) as fixed effects and a lipid x n3 interaction. P-values in bold are <0.10.  
2Fatty acids ≤0.2 not detailed.  
 Table 6. Retention (%) of macronutrients and fatty acids in the whole-body carcass of Atlantic salmon (n=3, pooled per tank). 
  Diets  Pooled Main Effect Means  Pooled P-values1 
  HL-Ln3 LL-Ln3 HL-Hn3 LL-Hn3 SE LL HL Ln3 Hn3 SE Lipid n3 Lipid x n3 
Protein 50.2b 43.0a 44.3ab 44.8ab 2.2 43.9 47.2 46.6 44.5 1.7 0.230 0.474 0.170 
Lipid 46.4 48.2 53.4 57.4 5.4 52.8 49.9 47.3 55.4 4.0 0.650 0.228 0.865 
Energy (MJ kg-1) 45.1 42.8 43.1 47.1 3.1 45.0 44.1 44.0 45.1 2.0 0.781 0.719 0.323 
Fatty acids2                  
14:0 38.5 39.1 47.1 50.0 8.2 44.6 42.8 38.8 48.6 5.6 0.847 0.296 0.904 
16:0 52.9 51.1 56.3 64.0 6.4 57.6 54.6 52.0 60.2 4.5 0.666 0.258 0.501 
18:0 66.4 68.3 63.8 81.4 6.8 74.8 65.1 67.3 72.6 5.2 0.220 0.494 0.312 
20:0 30.2 25.6 33.6 32.7 4.2 29.2 31.9 27.9 33.2 2.9 0.550 0.265 0.686 
Total saturated 53.8 52.7 56.1 64.5 6.5 58.6 54.9 53.2 60.3 4.6 0.602 0.328 0.498 
16:1n-9 184.4 178.1 131.8 140.8 23.2 159.4 158.1 181.2 136.3 16.4 0.954 0.091 0.751 
16:1n-7 39.6 41.2 49.2 55.1 7.0 48.2 44.4 40.4 52.1 5.0 0.621 0.150 0.778 
18:1n-9 56.9 52.2 58.7 68.2 5.7 60.2 57.8 54.6 63.4 4.3 0.697 0.174 0.265 
18:1n-7 40.3a 38.1a 49.3ab 64.8b 6.7 51.4 44.8 39.2 57.1 5.6 0.372 0.034 0.244 
20:1n-9 268.7 220.7 223.4 197.1 24.0 208.9 246.0 244.7 210.2 18.1 0.202 0.233 0.695 
22:1n-11 -41.7a -31.0ab -15.6bc -6.0c 6.5 -18.5 -28.7 -36.4 -10.8 6.0 0.186 0.006 0.939 
24:1n-9 -41.0a -32.5ab 6.0ab 12.0b 12.6 -10.3 -17.5 -36.8 9.0 11.1 0.641 0.015 0.936 
Total monounsaturated 57.4 52.7 59.6 69.0 6.1 60.8 58.5 55.1 64.3 4.5 0.728 0.184 0.300 
18:2n-6 37.3a 39.6a 47.4ab 56.6c 4.5 48.1 42.3 38.5 52.0 3.8 0.252 0.020 0.483 
20:4n-6 258.8b 289.8b 79.8a 92.9a 27.5 191.4 169.3 274.3 86.4 32.8 0.529 0.001 0.797 
Total n-6 PUFA 49.4a 53.0ab 56.8ab 68.7b 5.7 60.8 53.1 51.2 62.7 4.4 0.222 0.084 0.501 
18:3n-3 14.9a 17.0a 33.4b 39.7b 2.8 28.3 24.2 16.0 36.5 3.6 0.245 <0.001 0.549 
18:4n-3 7.8ab 7.0a 24.7bc 25.9c 5.1 16.4 16.2 7.4 25.3 4.3 0.970 0.862 0.590 
20:4n-3 48.9a 54.8a 141.1b 155.1b 15.3 105.0 95.0 51.9 148.1 17.6 0.590 0.001 0.824 
20:5n-3 10.8ab 3.2a 24.6b 20.9b 4.1 12.1 17.7 7.0 22.8 3.8 0.242 0.008 0.675 
22:5n-3 72.8a 81.0a 119.2b 125.4b 14.8 103.2 96.0 76.9 122.3 12.6 0.678 0.026 0.955 
22:6n-3 113.8 99.1 109.4 109.2 11.3 104.2 111.6 106.4 109.3 7.8 0.550 0.813 0.559 
Total n-3 PUFA 39.4ab 35.3a 52.7ab 55.3b 5.5 45.3 46.1 37.3 54.0 4.5 0.895 0.02 0.586 
Total PUFA 46.0 47.4 54.6 60.8 5.7 54.1 50.3 46.7 57.7 4.1 0.537 0.098 0.697 
Total LC-PUFA 111.5 103.3 81.0 84.4 11.1 93.8 96.3 107.4 82.7 8.3 0.838 0.065 0.627 
Total Fatty Acids 55.2 51.8 58.1 66.1 6.1 59.0 56.6 53.5 62.1 4.4 0.720 0.210 0.393 
HL; high lipid, Hn3; high n-3 LC-PUFA, LL; low lipid, Ln3; low n-3 LC-PUFA, SE; pooled standard error of the mean.  
1P-values from linear model with lipids and n-3 LC-PUFA (n3) as fixed effects and a lipid x n3 interaction. P-values in bold are <0.10. 
2Fatty acids <0.2% in the diet not detailed. 
  
Table 7. Apparent digestibility (%) of macronutrients and fatty acids for Atlantic salmon (n=3, pooled per tank). 
 Diets Pooled Main Effect Means Pooled P-value1 
  HL-Ln3 LL-Ln3 HL-Hn3 LL-Hn3 SE LL HL Ln3 Hn3 SE Lipid n3 Lipid x n3 
Protein 93.2c 92.0a 93.5d 92.8b 0.1 92.4 93.4 92.6 93.2 0.2 <0.001 <0.001 0.032 
Lipid 98.3b 97.3ab 95.6a 96.2a 0.6 96.8 97.2 97.8 96.1 0.5 0.517 0.025 0.424 
Energy (MJ kg-1) 89.0b 87.7a 88.9b 88.0ab 0.3 87.9 88.9 88.3 88.5 0.2 0.010 0.718 0.492 
Fatty acids2              
14:0 95.0 94.8 86.7 92.0 1.7 93.1 90.9 94.9 89.4 1.8 0.393 0.104 0.418 
16:0 97.8 97.1 92.8 94.4 1.1 95.5 95.3 97.5 93.6 1.0 0.725 0.043 0.497 
18:0 97.1 96.1 92.0 92.9 1.3 94.2 94.6 96.7 92.5 1.2 0.988 0.045 0.616 
20:0 97.3 95.7 93.0 92.8 1.4 94.0 95.2 96.7 92.9 1.1 0.613 0.051 0.684 
Total saturates 97.5 96.7 92.1 93.8 1.2 95.0 94.8 97.2 92.9 1.1 0.732 0.045 0.500 
16:1n-9 99.7 100.0 100.0 99.8 0.1 99.9 99.8 99.8 99.9 0.1 0.889 0.689 0.264 
16:1n-7 99.6 99.3 99.1 99.3 0.1 99.3 99.4 99.5 99.2 0.1 0.823 0.153 0.202 
18:1n-9 99.7 99.3 99.6 99.5 0.1 99.4 99.7 99.5 99.6 0.1 0.043 0.749 0.365 
18:1n-7 99.6b 99.3ab 99.2ab 98.9a 0.1 99.1 99.4 99.5 99.0 0.1 0.137 0.042 0.898 
20:1n-9 98.8 97.9 98.3 98.3 0.3 98.1 98.6 98.5 98.3 0.2 0.212 0.648 0.219 
22:1n-11 98.9 98.0 98.3 98.4 0.3 98.3 98.6 98.5 98.4 0.2 0.481 0.718 0.209 
24:1n-9 96.0 92.7 90.0 92.7 1.5 96.7 96.1 96.5 96.3 1.0 0.986 0.165 0.205 
Total monoenes 99.6 99.3 99.5 99.4 0.1 99.3 99.6 99.5 99.4 0.1 0.063 0.797 0.386 
18:2n-6 99.4 99.2 99.2 99.1 0.2 99.1 99.3 99.3 99.1 0.1 0.522 0.556 0.774 
20:4n-6 97.1a 96.5a 99.6b 98.9ab 0.7 97.9 98.3 96.9 99.2 0.6 0.457 0.017 0.928 
Total n-6 PUFA 99.3 99.1 99.1 99.0 0.2 99.1 99.2 99.2 99.1 0.1 0.565 0.569 0.740 
18:3n-3 99.6 99.4 99.7 99.7 0.1 99.6 99.6 99.5 99.7 0.1 0.416 0.195 0.435 
18:4n-3 99.2 99.1 99.4 99.6 0.2 99.4 99.3 99.1 99.5 0.1 0.726 0.072 0.485 
20:5n-3 99.7 99.6 99.8 99.8 0.1 99.7 99.7 99.6 99.8 0.1 0.707 0.155 0.774 
22:5n-3 99.3 98.6 99.8 99.3 0.3 99.0 99.6 99.0 99.6 0.3 0.209 0.180 0.845 
22:6n-3 98.5 98.1 99.2 99.0 0.4 98.6 98.8 98.3 99.1 0.3 0.529 0.129 0.823 
Total n-3 PUFA 99.3 99.1 99.6 99.5 0.2 99.3 99.4 99.2 99.5 0.1 0.527 0.134 0.701 
Total PUFA 99.3 99.1 99.3 99.3 0.2 99.2 99.3 99.2 99.3 0.1 0.552 0.646 0.676 
Total LC-PUFA 98.8 98.5 99.5 99.3 0.3 99.0 99.2 98.7 99.4 0.2 0.607 0.100 0.807 
Total 99.2 98.8 98.1 98.2 0.3 98.5 98.7 99.1 98.2 0.3 0.767 0.070 0.532 
HL; high lipid, Hn3; high n-3 LC-PUFA, LL; low lipid, Ln3; low n-3 LC-PUFA, SE; pooled standard error of the mean. 
1P-values from linear model with lipids and n-3 LC-PUFA (n3) as fixed effects and a lipid x n3 interaction. P-values in bold are <0.10. 
2Fatty acids <0.2% in the diet not detailed. 
  
 
Figure1. General nutrient response schematic showing the approximate relative levels at which 
responses by Atlantic salmon to variable n-3 LC-PUFA supply were observed based on the results 
from Glencross et al. (2014). In this example performance is projected to decline to a maintenance 
point consistent with the needs for conditionally-essential nutrients. Across the top of the figure are 
the relative levels of n-3 LC-PUFA (% of total fatty acids; TFA) in a diet with 200 g/kg of lipid, 
whereas along the bottom of the figure are the commensurate absolute n-3 LC-PUFA levels (g/kg). 
 
  




Figure 2. Interaction plot of mean weight gain based on total n-3 LC-PUFA intake of each tank of fish 
fed either high-lipid (red) or low-lipid (blue) diets. The cross-over of slopes indicate an interaction 
between dietary lipid and n-3 levels, where weight gain was more increased for fish fed high than low 
lipid diets at a similar n-3 intake. The higher slope of the high-lipid data shows that these diets are on 
a nutrient-dependent plane, whereas the low-lipid data are more closely representing responses on an 
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Figure3. Expression of genes (mean ± SE, n=6/treatment) relative to the geometric mean of two 
reference genes (hprt and rps5) involved in fatty acid synthesis in the liver of Atlantic salmon fed low 












































































































































Figure 4. Expression of genes relative to the geometric mean of two reference genes (hprt and rps5) 
involved in transcription factors in lipid regulation in the liver of Atlantic salmon fed low and high 







































































Figure 5. Expression of genes relative to the geometric mean of two reference genes (hprt and rps5) 
involved in beta oxidation of fatty acids in the liver of Atlantic salmon fed low and high levels of 































































































Figure 6. Expression of the relativity of n-3 LC-PUFA requirements by Atlantic salmon overlaid on to 
variable absolute dietary lipid levels (x-axis), absolute n-3 levels (left y-axis) and n-3 levels relative to 
lipid level (right y-axis). The four diets (i.e. LL-Ln3, HL-Ln3, LL-Hn3 and HL-Hn3) from this study 
are overlaid and show the n-3 level in relation to low (blue) and high (red) lipid level. The lower 
boundary between the orange and red is commensurate with an n-3 level at 4% of total fatty acids 
(TFA; marginal level), followed by the yellow and orange boundary at 5% TFA (threshold level), 
light-green and yellow boundary at 6% TFA (optimal level) and so on up to a 9%TFA level. Notable 
is how the actual (g/kg) level of n-3 in the diet needs to increase as dietary lipid level increases. An 
optimal level of 10 g/kg of n-3 in a diet with 200 g/kg of lipid being equivalent to an optimal level of 
15 g/kg of n-3 in a diet with 300 g/kg of lipid. 
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